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Arabinan polysaccharide side-chains are present in both Mycobacterium tuberculosis and
Corynebacterium glutamicum in the heteropolysaccharide arabinogalactan (AG), and in M.
tuberculosis in the lipoglycan lipoarabinomannan (LAM). This study shows by quantitative sugar
and glycosyl linkage analysis that C. glutamicum possesses a much smaller LAM version, Cg-
LAM, characterized by single t-Araf residues linked to the a(1A6)-linked mannan backbone.
MALDI-TOF MS showed an average molecular mass of 13800–15400 Da for Cg-LAM. The
biosynthetic origin of Araf residues found in the extracytoplasmic arabinan domain of AG and LAM
is well known to be provided by decaprenyl-monophosphoryl-D-arabinose (DPA). However, the
characterization of LAM in a C. glutamicum::ubiA mutant devoid of prenyltransferase activity and
devoid of DPA-dependent arabinan deposition into AG revealed partial formation of LAM, albeit
with a slightly altered molecular mass. These data suggest that in addition to DPA utilization
as an Araf donor, alternative pathways exist in Corynebacterianeae for Araf delivery, possibly via
an unknown sugar nucleotide.
INTRODUCTION
The Corynebacterianeae represent a distinct and unusual
group within Gram-positive bacteria, with the most
prominent members being the human pathogens
Mycobacterium tuberculosis and Mycobacterium leprae
(Bloom & Murray, 1992). Non-pathogenic bacteria also
belong to this taxon, such as Corynebacterium glutamicum,
which is used in the industrial production of amino acids
(Sahm et al., 2000) . These bacteria collectively belong to
the same suborder, and share a similar genome, cell
envelope and corresponding cell wall biosynthetic enzymes
(Dover et al., 2004; Stackebrandt et al., 1997).
The characteristic cell envelope of this distinct group of
bacteria contains mycolic acids, arabinogalactan (AG) and
peptidoglycan, which are covalently linked to each other to
form the mycolyl-arabinogalactan-peptidoglycan (mAGP)
complex (Besra et al., 1995; Brennan & Nikaido, 1995;
Brennan, 2003; Daffe ´ et al., 1990; Dmitriev et al., 2000;
Dover et al., 2004; McNeil et al., 1990, 1991). In addition,
they possess an array of cell-wall-associated glycolipids,
such as phosphatidyl-myo-inositol (PI), phosphatidyl-myo-
inositol mannosides (PIMs) and the lipoglycans lipoman-
nan (LM) and lipoarabinomannan (LAM) (Brennan
& Ballou, 1967, 1968; Chatterjee et al., 1991, 1993;
Guerardel et al., 2002; Hill & Ballou, 1966; Khoo et al.,
1995). As a result, arabinose is present in two polysacchar-
ides with markedly different structures. The occurrence of
Abbreviations: Ac, acylated; Ara, arabinose; Araf, arabinofuranose; AG,
arabinogalactan; DPA, decaprenyl-monophosphoryl-D-arabinose; DPM,
decaprenyl-monophosphoryl-mannose; DPR, decaprenyl-monophos-
phoryl-D-ribose; DPPR, decaprenyl-monophosphoryl-5-phosphoribose;
LAM, lipoarabinomannan; LM, lipomannan; Man, mannose; mAGP,
mycolyl-arabinogalactan-peptidoglycan; p, pyranose; PI, phosphatidyl-
myo-inositol; PIMs, phosphatidyl-myo-inositol mannosides; pRpp, 5-
phosphoribofuranose pyrophosphate; t-, terminal; TFA, trifluoroacetic
acid.
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nan & Nikaido, 1995), plants (Fincher et al., 1983) and
protozoan parasites (Dobson et al., 2003; Goswami et al.,
2006; Guha-Niyogi et al., 2001; Previato et al., 1982; Xavier
Da Silveira et al., 1998) and their absence in mammalian
cells is well known. Corynebacterianeae arabinan is an
extremely complex homopolymer of D-arabinofuranose (D-
Araf) residues based on discrete structural motifs; however,
the complete structures and biosynthesis of these polymers
are still to be established.
For LAM biosynthesis we initially proposed the following
biosynthetic pathway PIAPIMALMALAM (Besra et al.,
1997) in M. tuberculosis, which is now largely supported by
biochemical and genetic evidence (Gurcha et al., 2002;
Kordulakova et al., 2002; Kremer et al., 2002; Schaeffer
et al., 1999). PimA catalyses the addition of Manp provided
by GDP-mannose to the 2-position of the myo-inositol of
PI to form PIM1 (Kordulakova et al., 2002), whereas PimB
might be responsible for the addition of a second Manp to
the 6-position to yield Ac1PIM2 (Schaeffer et al., 1999;
Tatituri et al., 2007). PimC has been demonstrated to allow
further mannosylation to Ac1PIM3 (Kremer et al., 2002)
and more recently, PimE has been shown to be involved in
the biosynthesis of Ac1PIM5 (Morita et al., 2006). It has
been proposed that PIM4 is the direct precursor of LM,
characterized by a linear a(1A6)-linked mannan backbone
linked with a(1A2) mannopyranose side chains generated
through a mannosyltransferase encoded by Rv2181 (Kaur
et al., 2006). LM is then further glycosylated with arabinan
to produce LAM, and finally ‘mannose-capped’ to produce
ManLAM, a process initiated by the capping enzyme
encoded by Rv1635c (Dinadayala et al., 2006). For the
addition of arabinose residues into mycobacterial LAM,
EmbC is required (Berg et al., 2005; Shi et al., 2006;
Zhang et al., 2003), whereas AftA, EmbA and EmbB
perform arabinan polymerization in AG (Alderwick et al.,
2006b; Belanger et al., 1996; Escuyer et al., 2001). In
contrast, C. glutamicum possesses a singular Emb, and an
AftA orthologue, which are used in AG biosynthesis
(Alderwick et al., 2005, 2006b; Seidel et al., 2007). It is
interesting to note that the arabinan domains of AG and
LAM utilize several different Araf linkages, which suggests
that additional arabinofuranosyltransferases must be
required to form AG and LAM, and still remain to be
identified in Corynebacterianeae.
It has been shown that the activated Araf sugar donor in
Corynebacterianeae is decaprenyl-monophosphoryl-D-arabi-
nose (DPA) (Wolucka et al., 1994).It wasalso proposedthat
decaprenyl-monophosphoryl-D-ribose (DPR) could be an
additional precursor involved in arabinan synthesis, via a 29-
epimerase (Wolucka & de Hoffmann, 1995). Recently, it was
shown that 5-phosphoribofuranose pyrophosphate (pRpp)
is converted to decaprenyl-monophosphoryl-5-phosphor-
ibose (DPPR) via a 5-phospho-a-D-ribose-1-diphosphate-
decaprenyl-phosphate 5-phosphoribosyltransferase (UbiA;
Rv3806c and NCgl2781 in M. tuberculosis and C. glutami-
cum, respectively) (Huang et al., 2005), which is then
dephosphorylated to form DPR. DPR is then enzymically
oxidized to form a keto-intermediate, DPX, followed by an
enzymic reduction to DPA (Mikusova et al., 2005).
Additionally, disruption in C. glutamicum of ubiA, encoding
the first enzyme involved in the biosynthesis of DPA,
resulted in a complete loss of cell wall arabinan (Alderwick
et al., 2006a). To date, no sugar nucleotides of Araf have
been identified. The key discovery that Araf residues in AG
arise from DPA also raised the question whether mycobac-
teria neither produce nor require Araf sugar nucleotides.
Herein, we now clearly show that an ubiA-disrupted mutant
of C. glutamicum still produces a modified LAM variant
(Cg-LAM), which is arabinosylated even in the absence of
the sugar donor DPA (Alderwick et al., 2006a). Taken
together, the data suggest that alternative pathways may
exist in Corynebacterianeae, independent of DPA utilization,
specifically involved in arabinosylation events in Cg-LAM
biosynthesis.
METHODS
Strains, construction of plasmids and culture conditions. C.
glutamicum ATCC 13032 (the wild-type strain, referred to for the
remainder of the text as C. glutamicum) and Escherichia coli DH5amcr
were grown in Luria–Bertani broth (Difco) at 30 uC and 37 uC,
respectively. The C. glutamicum::ubiA mutant was grown on the
complex medium brain heart infusion (Difco). Kanamycin and
ampicillin were used at a concentration of 50 mgm l
21. The vector
used for inactivation of C. glutamicum::ubiA was pCg::ubiA.I t
contained an internal ubiA fragment of 321 bp amplified with the
primer pairs ATC TTC AAC CAG CGC ACG ATC and AAT ATC
GAT CAC TGG CAT GTG, which was ligated into the SmaI site of the
non-replicative vector pK18mob to yield pCg::ubiA. To enable
chromosomal inactivation of ubiA, pCg::ubiA was introduced into
C. glutamicum by electroporation (Alderwick et al., 2005).
Extraction and purification of lipoglycans. Purification proce-
dures were adapted from protocols established for the extraction and
purification of mycobacterial lipoglycans (Nigou et al., 1999). Briefly,
10 g of cells grown to an OD600 of 1.0, were delipidated at 60 uCb y
using 500 ml CHCl3/CH3OH (1:1, v/v). The delipidated cells were
resuspended in deionized water and disrupted by probe sonication
(MSE Soniprep 150, 12 mm amplitude, 60 s on, 90 s off for 10 cycles,
on ice) and the cell debris refluxed five times with 100 ml C2H5OH/
H2O (1:1, v/v) at 68 uC, for 12 h intervals. The cell debris was
removed by centrifugation and the supernatant containing lipogly-
cans, neutral glycans and proteins dried. The dried supernatant was
then treated with a hot 80% (w/w) phenol/H2O biphasic wash at
70 uC for 1 h, followed by several protease treatments, and the
lipoglycan fraction was recovered following extensive dialysis against
deionized water (Nigou et al., 1999).
The crude lipoglycan extract was resuspended in buffer A (50 mM
ammonim acetate and 15% propan-1-ol) and subjected to
octyl-Sepharose CL-4B hydrophobic interaction chromatography
(2.5 cm650 cm) as previously reported (Leopold & Fischer, 1993).
The column was initially washed with 4 column volumes of buffer A to
ensure removal of neutral glycans followed by an increasing gradient of
propan-1-ol ranging from 25 to 65%, keeping the concentration of
ammoniumacetateconstant. Theeluateswere collectedandextensively
dialysed against deionized water, concentrated to approximately 1 ml
and precipitated using 5 ml C2H5OH; the sample was freeze-dried
using a Savant SpeedVac. The freeze-dried sample containing the
R. V. V. Tatituri and others
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then resuspended in buffer B (0.2 M NaCl, 0.25%, w/v, sodium
deoxycholate, 1 mM EDTA and 10 mM Tris/HCl, pH 8) to a final
concentration of 200 mg ml
21. The sample was gently mixed and
left to incubate for 48 h at room temperature. The sample was
then loaded onto a Sephacryl S-200 column (2.5 cm650 cm)
previously equilibrated with buffer B. The sample was washed with
400 ml buffer C (0.2 M NaCl, 1 mM EDTA and 10 mM Tris/HCl,
pH 8) at a flow rate of 3 ml h
21, collecting 1.5 ml fractions using
a Bio-Rad auto-sampler. The fractions were monitored by SDS-
PAGE using either a silver stain utilizing periodic acid and silver
nitrate (Hunter et al., 1986) or a Pro-Q emerald glycoprotein stain
(Invitrogen), and individual fractions were pooled and dialysed
extensively against buffer C for 72 h with frequent changes. The
samples were further dialysed against deionized water for 48 h
with frequent changes of deionized water, lyophilized and stored at
220 uC.
Glycosyl composition and linkage analysis of lipoglycans by
alditol acetates. Lipoglycans from wild-type C. glutamicum and the
C. glutamicum::ubiA mutant were hydrolysed using 2 M trifluor-
oacetic acid (TFA), reduced with NaBD4, and the resultant alditols
were per-O-acetylated and examined by GC (Tatituri et al., 2007).
Lipoglycans (2 mg) were per-O-methylated using dimethyl sulfinyl
carbanion as described previously (Alderwick et al., 2005; Besra et al.,
1995; Daffe ´ et al., 1990). In this procedure, lipoglycan samples (2 mg)
were resuspended in 0.5 ml DMSO (anhydrous) and 100 ml of 4.8 M
dimethyl sulfinyl carbanion. The reaction mixture was stirred for 1 h
and then iodomethane (50 ml) was slowly added and the suspension
stirred for 1 h; this process was repeated for a total of three times. The
reaction mixture was then diluted with an equal volume of water,
dialysed against deionized water and dried. The resulting retentate
was applied to a pre-equilibrated C18 Sep-Pak cartridge and initially
washed with 10 ml water, 10 ml 20% acetonitrile, and the per-O-
methylated lipoglycan eluted with 2 ml acetonitrile and 2 ml ethanol.
After drying the combined organic eluate under nitrogen, the per-O-
methylated lipoglycan was hydrolysed using 250 ml 2 M TFA at
120 uC for 2 h. The resulting hydrolysate was reduced with NaBD4,
per-O-acetylated and examined by GC/MS (Tatituri et al., 2007). Per-
O-methylation of lipoglycans for matrix-assisted laser desorption
ionization-mass spectrometry (MALDI-MS) analysis was performed
as described previously (Dell et al., 1993). Briefly, 1 ml of a DMSO/
NaOH slurry was added followed by 0.5 ml of iodomethane. The
reaction mixture was vigorously shaken for 10 min at room
temperature and the reaction quenched with 1 ml water. Per-O-
methylated samples were then extracted into chloroform (1 ml) and
washed several times with water before drying under a stream of
nitrogen.
GC and GC/MS analysis. Analysis of partially per-O-methylated,
per-O-acetylated alditol acetate sugar derivatives was performed on a
CE Instruments ThermoQuest Trace GC 2000. Samples were injected
in the split mode. The column used was a DB225 (Supelco). The oven
was programmed to hold at an isothermal temperature of 275 uC for
a run time of 15 min. GC/MS was carried out on a BPX5 column
(Supelco) and a Finnigan Polaris/GCQ PlusTM, as described
previously (Besra et al., 1995; Daffe ´ et al., 1990). GC/MS analysis of
alditol acetate sugar derivatives was performed on a Perkin Elmer
Clarus 500 instrument. Samples were injected in the splitless mode.
The column used was an RTX-5 (30 m60.25 mm internal diameter,
Restek Corp.). Initial temperature was set at 60 uC then ramped to
300 uCa t8uC min
21.
NMR spectroscopy. NMR spectra of lipoglycans were recorded on a
Bruker DMX-500 equipped with a double-resonance (1H/X)-BBi z-
gradient probe head. All samples were exchanged in D2O (D, 99.97%;
Euriso-top), with intermediate lyophilization, and then dissolved in
0.5 ml D2O and analysed at 313 K. The
1H and
13C NMR chemical
shifts were referenced relative to internal acetone at 2.225 and
34.00 p.p.m., respectively. All the details concerning NMR sequences
used and experimental procedures were described in previous studies
(Gilleron et al., 1999, 2000; Nigou et al., 1999).
MALDI-MS analysis. MALDI-MS was performed using a PerSeptive
Biosystems Voyager DE STR mass spectrometer. Native lipogycans
were dissolved in CH3OH/H2O (50:50, v/v) and 1 ml of the sample
was loaded onto a metal plate. After evaporation, 1 ml of the matrix
2,5-dihydroxybenzoic acid was added on the spot. Samples were
analysed using the linear negative mode. Per-O-methylated samples
were dissolved in CH3OH/H2O (80:20, v/v) and analysed in the
linear positive mode using 2,5-dihydroxybenzoic acid as matrix.
Sequazyme peptide mass standards (Applied Biosystems) were used as
external calibrants.
RESULTS
Disruption of Cg-ubiA
The ubiA gene product was shown in prior work to
synthesize DPPR, which is converted to DPA, thus
supplying the substrate for the ‘priming’ arabinosyltrans-
ferase AftA (Alderwick et al., 2006b). These initial Araf
residues ‘prime’ the galactan backbone for further attach-
ment of a(1A5)-linked Araf residues. These reactions
require the arabinofuranosyltransferase activities of Mt-
EmbA and Mt-EmbB, or Cg-Emb, respectively, and also
the utilization of DPA (Alderwick et al., 2005; Escuyer et al.,
2001; Seidel et al., 2007), to eventually result in mature AG.
In light of our present studies demonstrating the
occurrence of Cg-LAM we inactivated the mycobacterial
orthologue of C. glutamicum, NCgl2781, by transforming
the wild-type to kanamycin resistance conferred by the
vector-borne aph gene product of pCg::ubiA with a view
to generating a clear C. glutamicum LM-only phenotype.
The vector, as previously described (Alderwick et al.,
2005), was integrated into the chromosomal ubiA gene,
thus disrupting ubiA, as confirmed by two independent
PCR analyses with two different primer pairs (Alderwick
et al., 2005). As expected, the resulting strain C. gluta-
micum::ubiA exhibited strongly reduced growth (Alder-
wick et al., 2006a).
Purification of lipoglycans from C. glutamicum
and C. glutamicum::ubiA
Analysis of the crude phenol-extracted lipoglycans from C.
glutamicum (Fig. 1a) and C. glutamicum::ubiA (Fig. 1b)
visualized on SDS-PAGE revealed two closely migrating
lipoglycans. A two-step purification protocol was per-
formed to fractionate the crude lipoglycans. In the first
step, the neutral glycans and nucleic acids were eliminated
by using an octyl-Sepharose CL-4B column (Amersham
Biosciences). In the second step, the lipoglycans were
individually purified using a Sephacryl S-200 column
(Amersham Biosciences). Fractions containing the lipogly-
cans were monitored by SDS-PAGE stained with either
Arabinosylated LAM variant from a C. glutamicum ubiA mutant
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pooled accordingly to afford lower (1) and upper (2)
lipoglycans (Fig. 1a, b).
General structural features of lipoglycans from C.
glutamicum and C. glutamicum::ubiA
The lower lipoglycans (1) from both C. glutamicum and C.
glutamicum::ubiA were similar and exhibited the basic
components of a structure related to mycobacterial LM
(now termed Cg-LM) and contained solely mannopyr-
anose (Manp). Per-O-methylation analysis of Cg-LM from
both strains indicated the presence of t-Manp, 2-Manp,6 -
Manp and 2,6-Manp residues (Tatituri et al., 2007). GC
analysis of the total acid-hydrolysed upper lipoglycan (2)
from C. glutamicum showed that it contained arabinose
and mannose in a ratio of 23:77 and was related to
mycobacterial LAM (Fig. 2a). Per-O-methylation analysis
of wild-type Cg-LAM indicated the presence of t-Araf, t-
Manp, 2-Manp, 6-Manp and 2,6-Manp residues (Fig. 3a).
Interestingly, Cg-LAM of the wild-type strain was pre-
viously shown to be composed of a PI anchor linked to an
a(1A6)Manp backbone substituted at most of the O-2
positions by the structural motifs t-Araf, t-Manp, t-
Araf(1A2)-Manp and t-Manp(1A2)-Manp units (Fig. 4e)
(Tatituri et al., 2007). Accordingly, the 1D
1H-NMR
anomeric region (Fig. 4a) exhibited a complex pattern of
overlapping resonances corresponding to Araf and Manp
units. The different spin systems were characterized by
1H-
13C HMQC NMR (Fig. 4b) and anomeric resonances
were attributed as follows: dH1C15.20/112.2 (I1) to two
overlapping t-Araf units (see below) and 5.13/112.0 (II1)t o
a third t-Araf unit, 5.06/105.2 (III1)t ot-Manp units, 5.12/
101.4 (IV1), 5.07/101.7 (V1) and 5.04/101.9 (VI1) to 2,6-
Manp units, 5.06/105.2 (VII1) to 6-Manp units, and 5.00/
104.9 (VIII1) to 2-Manp units.
Our previous experiments demonstrated that the C.
glutamicum::ubiA mutant failed to synthesize DPA
(Alderwick et al., 2006a) and possessed an arabinan-
deficient cell wall phenotype (Alderwick et al., 2005). As a
consequence, we anticipated that the Cg-LAM from the
mutant would be devoid of arabinose. Surprisingly,
glycosyl compositional analysis of Cg-LAM from the C.
glutamicum::ubiA mutant showed that it contained
arabinose, albeit in substantially smaller amounts, and
mannose in a ratio of 4.5:95.5 (Fig. 2b). Per-O-methyl-
ation analysis of Cg-LAM from the mutant indicated the
Fig. 1. Lipoglycan profiles of wild-type C.
glutamicum (a) and C. glutamicum::ubiA (b).
Lipoglycans were analysed using SDS-PAGE
and visualized using the Pro-Q emerald
glycoprotein stain (Invitrogen) specific for
carbohydrates. Individual lipoglycans (1 and
2) were purified as described in Methods. C,
crude lipoglycan; M, molecular mass markers
(kDa).
Fig. 2. Glycosyl compositional analysis of lipoglycan-2 from wild-
type C. glutamicum (a) and C. glutamicum::ubiA (b). Samples of
individually purified lipoglycans (2) were hydrolysed with 2 M TFA,
reduced and per-O-acetylated. Alditol acetates were subjected to
GC analysis. Peak area integration shows that the arabinose
content is 23% in wild-type C. glutamicum (a) and 4.5% in the C.
glutamicum::ubiA mutant (b). Ara, arabinose; Man, mannose.
R. V. V. Tatituri and others
2624 Microbiology 153presence of t-Araf, t-Manp, 2-Manp, 6-Manp and 2,6-
Manp, although the relative abundance of t-Araf residues
was reduced (Fig. 3b). In agreement with the glycosyl
compositional and linkage analysis data indicating a
reduced amount of t-Araf units, the 1D
1H anomeric
region of Cg-LAM from the glutamicum::ubiA mutant
(Fig. 4c) was simpler than that observed for Cg-LAM from
wild-type C. glutamicum (Fig. 4a). Resonance I1, corre-
sponding to a t-a-Araf unit, was dramatically reduced,
suggesting two overlapping t-Araf signals. This was further
confirmed by
1H-
13C HMQC analysis (Fig. 4d). Indeed, the
relative intensity of the correlation at dH1C15.20/112.2 (I1)
was much weaker and correlation at dH1C1 5.13/112.0 (II1)
of the third t-Araf residue was absent.
The native Cg-LAMs from wild-type C. glutamicum and
the C. glutamicum::ubiA mutant were analysed by MALDI
TOF MS. MALDI spectra were performed in the linear
negative mode. The mass spectra show broad unresolved
molecular ion envelopes due to the heterogeneity of the
Cg-LAMs and the relatively low resolution of this type of
MS. The native Cg-LAM from wild-type C. glutamicum
shows an average molecular mass of around 15400 Da
(Fig. 5a). The native Cg-LAM from the C. gluta-
micum::ubiA mutant shows a somewhat lower average
molecular mass in the region of 13900 Da (Fig. 5b).
Samples of Cg-LAM from wild-type C. glutamicum and C.
glutamicum::ubiA were subjected to per-O-methylation
and analysed by MALDI TOF MS (data not shown).
Per-O-methylation replaces fatty acyl substituents with
methyl groups as well as methylating all the free hydroxyl
groups. The average molecular mass of the derivatized Cg-
LAM from wild-type C. glutamicum was observed around
15600 Da, whilst the molecular mass of the corresponding
Cg-LAM from C. glutamicum::ubiA was observed around
15200 Da.
Altogether, these data indicate that the C. glutamicum
::ubiA mutant produces a slightly truncated Cg-LAM with
a severe reduction in t-Araf content but maintaining and
possibly extending its mannan core. In addition, the
presence of UbiA and the biosynthesis of DPA appear to be
essential for the higher arabinosylation of Cg-LAM.
Moreover, these findings suggest that arabinose deposition
in the C. glutamicum::ubiA mutant is a result of incor-
poration of t-Araf through another arabinose substrate,
and one which is not DPA dependent.
DISCUSSION
Understanding the biosynthesis of mycobacterial arabinan
is paramount to identifying potential new drug targets for
the treatment of tuberculosis. However, as discussed earlier
our understanding of these pathways is far from complete.
In this respect, C. glutamicum is a useful tool in under-
standing mycobacterial cell wall biosynthesis, since this
organism possesses the core structural elements of
Corynebacterianeae with few gene duplications, and dele-
tion of orthologous genes, which is often lethal in
mycobacterial species, is possible (Alderwick et al., 2005,
2006b; Gande et al., 2004). Specifically, the deletion of the
DPA requiring arabinosyltransferase Emb in C. glutamicum
resulted in a strongly abrogated arabinan domain of AG
(Alderwick et al., 2005), and deletion of AftA also disabled
attachment of the remaining singular t-Araf residues to
galactan (Alderwick et al., 2006b). Furthermore, the loss of
DPA synthesis in a C. glutamicum::ubiA mutant also
resulted in the full loss of the arabinan domain in mature
AG (Alderwick et al., 2005). In contrast, Cg-LM and Cg-
LAM isolated from the corresponding C. glutamicum Demb
and DaftA mutants were similar to the wild-type glycans
(data not shown). An absence of Araf residues was expected
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Fig. 3. Glycosyl linkage analysis of per-O-
methylated lipoglycan-2 from C. glutamicum
(a) and C. glutamicum::ubiA (b). Lipoglycan 2
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http://mic.sgmjournals.org 2625in Cg-LAM of the C. glutamicum::ubiA mutant. Strikingly,
a total absence of arabinan was not observed (Fig. 2),
thus requiring an alternative source and mechanism of
addition of this sugar which may be attributed to the
presence of an uncharacterized nucleotide sugar donor in
Corynebacterineae.
In contrast to mycobacteria, parasites do synthesize and
utilize a sugar nucleotide to provide an activated arabinose
sugar donor. Schneider et al. (1994) characterized GDP-a-
D-Arap, the precursor of D-Ara in Leishmania major
lipophosphoglycan. In trypanosomatids, this sugar nucleo-
tide is believed to be synthesized in a two-step process
(a) (c)
(b)
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114
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Fig. 4. (a–d) NMR characterization of wild-type Cg-LAM (a, b)
and Cg-LAM from the UbiA mutant (c, d). 1D
1H (a, c) and 2D
1H-
13C HMQC (b, d) NMR spectra of Cg-LAMs in D2O at 313 K.
Expanded regions (d
1H: 4.85–5.30) (a, c) and (d
1H: 4.85–5.30, d
13C: 100–114) (b, d) are shown. Glycosyl residues are labelled in
Roman numerals and their carbons and protons in Arabic. I, II, t-a-
Araf; III, t-a-Manp; IV, V, VI, 2,6-a-Manp; VII, 6-a-Manp; VIII, 2-a-
Manp. (e) Structural representation of Cg-LAM (Tatituri et al.,
2007). Cg-LAM contains a (1A6)-Manp backbone almost
completely substituted by t-Araf, t-Manp, t-Manp(1A2)-Manp
and t-Araf(1A2)-Manp units. X, either a t-Araf or a t-Manp unit.
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Fig. 5. MALDI-TOF MS spectra of Cg-LAM from wild-type C.
glutamicum (a) and C. glutamicum::ubiA (b). MALDI spectra
were acquired in the linear negative mode with delayed extraction
using 2,5-dihydrobenzoic acid as matrix.
Fig. 6. Proposed biosynthetic pathway of Cg-LAM. The addition of the first Araf unit is thought to occur on the cytoplasmic side
of the membrane by a GT-A/B glycosyltransferase (Liu & Mushegian, 2003). After transportation across the membrane by an
unknown ‘flippase’ enzyme, further elaboration of the lipoglycan then occurs through the addition of mannose and arabinose
units catalysed by several GT-C glycosyltransferases utilizing DPM and DPA, respectively (Berg et al., 2007; Seidel et al.,
2007; Tatituri et al., 2007).
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GDP-Ara pyrophosphorylase, whereby arabinose is phos-
phorylated to form arabinose 1-phosphate and then
activated to the nucleotide level by GDP-D-Arap pyrophos-
phorylase (Mengeling & Turco, 1999; Schneider et al.,
1995). Compared with the many genes encoding glycosyl-
transferases in prokaryotic and eukaryotic systems, very
little is known about those that encode arabinopyranosyl-
transferases. Dobson et al. (2003) identified two genes
(SCA1/2) encoding arabinosyltransferases mediating scAra
capping, and recently it was demonstrated by heterologous
expression that Leishmania SCA1 encodes an arabinopyr-
anosyltransferase (Goswami et al., 2006).
Glycosyltransferases belonging to one of the families, GT-A
and GT-B, or both, may be responsible for the initial
addition of t-Araf residues on to Cg-LAM in the absence of
DPA. These enymes may be present on the cytoplasmic side
of the membrane and probably aid in the transfer of t-Araf
residues from a putative sugar nucleotide donor. These
results could explain the presence of t-Araf in Cg-LAM,
even though DPA biosynthesis has been completely
abrogated in the C. glutamicum::ubiA mutant
(Alderwick et al., 2005). The mechanism by which these
Araf residues are added is not clear. One possible
explanation is that Araf residues from a nucleotide
precursor are added in a step-wise fashion to Cg-LM on
the cytoplasmic side to give motif A proximal to PI, and
then this complex polysaccharide is then probably flipped
on to the periplasmic side. It is thought that the flipping
mechanism is a prerequisite for arabinosylation to occur
outside of the membrane, where the arabinan and mannan
domains are formed through specific GT-C glycosyltrans-
ferases, by the addition of either t-Araf and t-Manp
residues, from DPA or decaprenyl-monophosphoryl-D-
mannose (DPM) to give motifs B, C and D (Figs 4e and 6)
(Berg et al., 2007; Seidel et al., 2007; Tatituri et al., 2007).
The biosynthetic origin of mycobacterial Araf residues is
generally a poorly understood area. To date, no sugar
nucleotides of Araf have been identified, and as a result, a
number of theories regarding the generation of arabinan in
mycobacteria have been put forward (Huang et al., 2005;
Mikusova et al., 2005; Scherman et al., 1995, 1996).
Depending on the organization of the arabinan chains, it is
speculated that five or six arabinofuranosyltransferases are
required for arabinan biosynthesis in mycobacteria. In this
regard, it is interesting to note that an M. smegmatis embC
mutant (Escuyer et al., 2001; Zhang et al., 2003) was found
to be devoid of LAM but from the chemical analysis, the
resulting LM precursor possessed two or three Araf
residues. The possibility exists that these residues are
initially added via a non-DPA-dependent glycosyltransfer-
ase; this requires further investigation.
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